This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Learn about the efficacy and safety of Somavert, its tumour impact and its effect on co-morbidity management through clinical and real world data

The acromegaly disease activity tool designed to help monitor your patients

Advice and support services to help you and your patients optimise your experience with Somavert about the efficacy and safety of Somavert through clinical and real world data

Learn about funding and reimbursement England, Scotland, Wales and Northern Ireland

Watch and listen to acromegaly experts talk about various topics in the disease area as well as recordings from our National Nurse Meeting and the Acromegaly co-morbidity series

Click here for Somavert® (pegvisomant) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

Somavert

Somavert is used in the treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalise IGF-I concentrations or was not tolerated.

Somavert efficacy and safety

Discover IGF-I normalisation rates with Somavert and learn about the safety profile

Learn more 

Initiating Somavert

Watch this step by step guide to applying for NHSE funding via Blueteq
​​​​​​​

Learn more

Acromegaly Expert Webinars 

Hear from experts on acromegaly and its management, captured from a variety of national and international opinion

Discover more webinars

Rare Disease Insight - Acromegaly Co-morbidities Webinars

Watch and listen to our Rare Disease Insight series where expert speakers take a deep dive into the co-morbidities associated with acromegaly

Watch the webinars now

Somavert dosing
​​​​​​​

Help find your patients' personal optimum by titrating doses 
​​​​​​​

Learn more

Register with ease

Get access to valuable resources and get support that is relevant to you.

Register

** This is an optional area where footnotes can live.

ACRODAT: The Acromegaly Disease Activity Tool 

Track IGF-I, symptoms and co-morbidities to help monitor and optimise support for your acromegaly patients at every stage of their journey

Explore more 

Supporting your Somavert patients
​​​​​​​

Discover more about the support services available to your acromegaly patients including starter kits and enhanced homecare

Learn more

Explore more

Card Header

The card body Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam.

Contact us for information on our support services

** This is an optional area where footnotes can live.


Register with ease

Get access to valuable resources and get support that is relevant to you.


​​​​​
​​​​​​​

Sign in or register

PP-SOM-GBR-0951. June 2021

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No